JP4191825B2 - ５−アミノイソキサゾール誘導体 - Google Patents

５−アミノイソキサゾール誘導体 Download PDF

Info

Publication number
JP4191825B2
JP4191825B2 JP27246798A JP27246798A JP4191825B2 JP 4191825 B2 JP4191825 B2 JP 4191825B2 JP 27246798 A JP27246798 A JP 27246798A JP 27246798 A JP27246798 A JP 27246798A JP 4191825 B2 JP4191825 B2 JP 4191825B2
Authority
JP
Japan
Prior art keywords
group
isoxazole
pyridyl
fluorophenyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP27246798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000086657A5 (enrdf_load_stackoverflow
JP2000086657A (ja
Inventor
信義 南
通隆 佐藤
幸市 蓮見
則夫 山本
勝幸 慶野
照明 松井
有弘 金田
修治 太田
教久 斎藤
秀一郎 佐藤
章 朝烏
知 土井
基博 小林
潤 佐藤
創 浅野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Aska Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aska Pharmaceutical Co Ltd filed Critical Aska Pharmaceutical Co Ltd
Priority to JP27246798A priority Critical patent/JP4191825B2/ja
Publication of JP2000086657A publication Critical patent/JP2000086657A/ja
Publication of JP2000086657A5 publication Critical patent/JP2000086657A5/ja
Application granted granted Critical
Publication of JP4191825B2 publication Critical patent/JP4191825B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP27246798A 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体 Expired - Lifetime JP4191825B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27246798A JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27246798A JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Publications (3)

Publication Number Publication Date
JP2000086657A JP2000086657A (ja) 2000-03-28
JP2000086657A5 JP2000086657A5 (enrdf_load_stackoverflow) 2005-10-20
JP4191825B2 true JP4191825B2 (ja) 2008-12-03

Family

ID=17514333

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27246798A Expired - Lifetime JP4191825B2 (ja) 1998-09-10 1998-09-10 ５−アミノイソキサゾール誘導体

Country Status (1)

Country Link
JP (1) JP4191825B2 (enrdf_load_stackoverflow)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1312601A4 (en) * 2000-08-22 2005-09-21 Ono Pharmaceutical Co CARBOXYLENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
AU2001278772A1 (en) * 2000-09-01 2002-03-22 Ono Pharmaceutical Co. Ltd. Benzoic acid derivatives and drugs containing the same as the active ingredient
IL154710A0 (en) * 2000-09-15 2003-10-31 Vertex Pharma Isoxazole derivatives and pharmaceutical compositions containing the same
JP2004521892A (ja) * 2000-12-20 2004-07-22 メルク　エンド　カムパニー　インコーポレーテッド （ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
ES2278170T3 (es) 2002-07-09 2007-08-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
MX2007004560A (es) 2004-10-16 2007-06-08 Astrazeneca Ab Proceso para hacer compuestos de fenoxi benzamida.
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
KR101181692B1 (ko) 2004-12-28 2012-09-19 아스카 세이야쿠 가부시키가이샤 피리미디닐이속사졸 유도체
BRPI0607688A2 (pt) 2005-02-17 2009-09-22 Synta Pharmaceuticals Corp método para inibir a polimerização de tubulina em uma célula; método para tratar ou prevenir um distúrbio proliferativo em um indivìduo; método para bloquear, ocluir ou de outro modo romper o fluxo sangüìneo na neovasculatura; composto; composição farmacêutica e uso do referido método e composto
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
KR101346902B1 (ko) 2005-07-09 2014-01-02 아스트라제네카 아베 당뇨병 치료에 있어 ｇｌｋ 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체
BRPI0617948A2 (pt) 2005-10-28 2011-08-09 Takeda Pharmaceutical composto, pró-droga de um composto, agente farmacêutico, método para inibir uma metaloproteinase de matriz, e, uso de um composto
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
JP4975758B2 (ja) * 2005-12-27 2012-07-11 ウニベルシダッド、デル、パイス、バスコ‐エウスカル、エリコ、ウニベルトシタテア、（ウペウベ‐エアチェウ） ヒストンデアセチラーゼ阻害活性を有する新規ピロール誘導体
JPWO2008001929A1 (ja) * 2006-06-28 2009-12-03 あすか製薬株式会社 炎症性腸疾患の処置剤
KR101412943B1 (ko) 2006-06-28 2014-06-26 아스카 세이야쿠 가부시키가이샤 피리딜이소옥사졸 유도체
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
TW200833339A (en) 2006-12-21 2008-08-16 Astrazeneca Ab Novel crystalline compound
AU2008215659B2 (en) 2007-02-16 2012-11-01 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
WO2008157162A1 (en) * 2007-06-13 2008-12-24 Bristol-Myers Squibb Company Dipeptide analogs as coagulation factor inhibitors
BRPI0917589A2 (pt) 2008-08-04 2015-11-17 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, método para tratar doenças, processo, combinação farmacêutica, e, reação de metiloxirano-2-carboxilato (ix) com um álcool roh
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
AR076221A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
WO2019022152A1 (ja) 2017-07-26 2019-01-31 学校法人同志社 ＴＧＦ－βシグナルに起因する障害を治療または予防するための医薬およびその応用

Also Published As

Publication number Publication date
JP2000086657A (ja) 2000-03-28

Similar Documents

Publication Publication Date Title
JP4191825B2 (ja) ５−アミノイソキサゾール誘導体
JP4632544B2 (ja) アミノピラゾール誘導体
JP5119157B2 (ja) カゼインキナーゼｉｉ（ｃｋ２）モジュレーターとしてのピラゾロ−ピリミジン類
US20120245142A1 (en) 3-oxo-2,3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
WO2016057779A2 (en) Induction of gata2 by hdac1 and hdac2 inhibitors
JP2015071622A (ja) 医薬品
JP2010508288A (ja) キナーゼ阻害剤として有用なヘテロサイクリックアミド化合物
JP2005519074A (ja) 治療用の置換インダゾール誘導体
KR102420263B1 (ko) 신규한 퀴나졸린 리독스 유도체 및 bet 억제제로서의 용도
JP5634263B2 (ja) キナゾリンジオンキマーゼ阻害剤
US9120780B2 (en) Indole or indazole derivative or salt thereof
KR102420262B1 (ko) 신규한 퀘르세틴 리독스 유도체 및 bet 억제제로서의 용도
JP2002088073A (ja) 抗アンドロゲン剤
JP5244591B2 (ja) ピリジルイソオキサゾール誘導体
JP2012509352A (ja) Ｂａｃｅ１のキナゾリン阻害剤および使用方法
WO2016120850A9 (en) Sulfonamide-subsituted indole modulators of rorc2 and methods of use thereof
JPWO2009123080A1 (ja) インドリノン化合物
US6627647B1 (en) Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents
JPWO2008001929A1 (ja) 炎症性腸疾患の処置剤
ES2609459T3 (es) Compuestos heterocíclicos condensados y su uso
JP4550353B2 (ja) 造血器型プロスタグランジンｄ２合成酵素阻害剤
US20250221977A1 (en) Novel benzothiophene derivative and use thereof as bet inhibitor
CN115784991B (zh) N-(苯磺酰基)酰胺衍生物及其制备方法和用途
WO2019222134A1 (en) Coup-tfii receptor inhibitors and methods using same
JP5424187B2 (ja) アシルアミノフェニル基を有する抗がん剤

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050620

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050620

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080126

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080624

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080916

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080919

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110926

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110926

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120926

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120926

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130926

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term